Solvay
BE0003470755 Short position disclosed on August 6, 2026.
2.07% of the capital sold short
3 disclosing funds
5 disclosures on record
Funds holding Solvay Titelia
Evolution of the disclosed total
0%1%2%3%
May 7May 31Jun 24Jul 18
Open positions
| Fund | Twelve months | % of capital | Over the year | Since |
|---|---|---|---|---|
| Gladstone Capital Management LLP | 0.70% | new | July 1, 2026 | |
| Davidson Kempner European Partners, LLP | 0.69% | unchanged | April 13, 2026 | |
| Citadel Advisors Europe Limited | 0.68% | new | August 6, 2026 |
History of disclosures
| Date | Fund | % of capital | End of publication |
|---|---|---|---|
| August 6, 2026 | Citadel Advisors Europe Limited | 0.68% | still open |
| August 5, 2026 | Citadel Advisors Europe Limited | 0.70% | still open |
| July 29, 2026 | Citadel Advisors Europe Limited | 0.60% | still open |
| July 1, 2026 | Gladstone Capital Management LLP | 0.70% | still open |
| April 13, 2026 | Davidson Kempner European Partners, LLP | 0.69% | still open |
Other companies sold short in Belgium
- Biocartis 1.21% of the capital sold short
- Barco 1.02% of the capital sold short
- CP Invest 0.98% of the capital sold short
- D'Ieteren Group 0.89% of the capital sold short
- Syensqo 0.89% of the capital sold short
- EVS 0.80% of the capital sold short
- Lotus Bakeries 0.79% of the capital sold short
- Umicore 0.70% of the capital sold short
- Sequana Medical 0.69% of the capital sold short
- Kinepolis 0.67% of the capital sold short
- Azelis 0.61% of the capital sold short